Los Angeles, CA, March 19, 2018 -- M2 Compliance® ("M2"), www.m2compliance.com, a world-leading filing agent registered with the Securities and Exchange Commission and full-service provider of EDGAR, XBRL, Inline XBRL (iXBRL) and print- related services, announced today its participation as a sponsor of the 28th Annual Oppenheimer Healthcare Conference scheduled for March 20-21, 2018 at The Westin New York Grand Central in New York City.
|
|||||
M2 is known for its UNLIMITED® EDGAR & XBRL PROGRAM for $4,995 per year, a revolutionary product for publicly traded companies and reporting issuers required to file electronic forms and disclosures to the U.S. Securities & Exchange Commission “SEC”. M2 has been in business for nearly 10 years and has saved over $5,000,000 to clients combined when compared to the fees they would have spent with other providers. M2's UNLIMITED® program was created to serve public companies with a market cap less than 500M and to bring the pricing down across the industry, all while delivering expedited turnaround times, 24/7 service, and reliable data in compliance with the latest SEC guidelines.
"For years, public companies have been gouged by other filing agents by excessive charges for per page rates, changes, and other fees for any part of the production process. The cost reductions are important but not as important as the quality of service, that's why we hold a 99% retention rate with clients and represent 1/4 of all public companies with a market cap under 500M to date. It is our mission to provide an improved service offering and reduce reporting costs significantly," said David McGuire, Founder & CEO of M2.
M2 is the only financial printer in the industry to offer a full-service and truly UNLIMITED® program for EDGAR & XBRL. The UNLIMITED® program translates into, not just a package for regulatory filings, but rather an UNLIMITED® compliance structure which also includes author's alterations, images, exhibits, financial tables, and everything else required for EDGAR & XBRL, all without any hidden fees and without any compromise on service. M2 does offer UNLIMITED® programs for companies that have a market cap above 500M, but these are based on customized quotes.
About the 28th Annual Oppenheimer Healthcare Conference
Investors will have the opportunity to hear and meet face to face with over 100 corporate management leaders from public and private companies at the forefront of the biopharmaceutical, biotechnology, medical device, life science tools and diagnostics, health technology and distribution, and healthcare facility, provider and service industries. There will also be presentations regarding emerging market opportunities and the current mergers and acquisitions climate. This significant two-day Conference of established institutional clients of Oppenheimer & Co. will be held at the Westin New York Grand Central in New York, New York for two days from Tuesday, March 20, 2018 through Wednesday, March 21, 2018.
About M2 Compliance®
M2 Compliance® is a full-service financial filing and printing firm and a leading partner for all your EDGAR & XBRL filing needs. With hundreds of public company clients, M2 is one of the fastest-growing regulatory compliance companies worldwide. M2 partners with customers to provide the knowledge and service necessary to meet the SEC's ever-changing filing regulations. M2 provides high-quality, cost-effective compliance filings and production services, including EDGAR filings, typesetting, XBRL tagging, financial printing, Inline XBRL, Section 16 filings, investment management services, drafting sessions, compliance hosting and more. For more information visit: www.m2compliance.com
Contact Information
Rafael McGuire
(310) 626-0800
[email protected]
www.inlineXBRL.com
www.iXBRL.com


Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



